background
respiratori
viral
infect
increas
risk
chronic
lung
allograft
dysfunct
lung
transplant
mechan
unknown
studi
determin
whether
symptomat
respiratori
viral
infect
lung
transplant
induc
circul
exosom
contain
lungassoci
selfantigen
assess
whether
exosom
activ
immun
respons
selfantigen
method
serum
sampl
collect
lung
transplant
recipi
symptomat
lowerand
uppertract
respiratori
viral
infect
nonsymptomat
stabl
recipi
exosom
isol
via
ultracentrifug
puriti
determin
use
sucros
cushion
presenc
lung
selfantigen
proteasom
viral
antigen
rhinoviru
coronaviru
respiratori
syncyti
viru
determin
use
immunoblot
mice
immun
circul
exosom
group
result
differenti
immun
respons
lung
histolog
analyz
result
exosom
contain
selfantigen
proteasom
viral
antigen
detect
significantli
higher
level
p
serum
recipi
symptomat
respiratori
viral
infect
n
compar
stabl
control
n
mice
immun
exosom
recipi
respiratori
viral
infect
develop
immun
respons
selfantigen
fibrosi
small
airway
occlus
signific
cellular
infiltr
mice
immun
exosom
control
p
conclus
circul
exosom
isol
lung
transplant
recipi
diagnos
respiratori
viral
infect
contain
lung
selfantigen
viral
antigen
proteasom
elicit
immun
respons
lung
selfantigen
result
develop
chronic
lung
allograft
dysfunct
immun
mice
exosom
graft
reject
respiratori
viral
infect
lung
transplant
chronic
reject
antigen
antibodi
lung
allograft
failur
chronic
lung
allograft
dysfunct
clad
lead
caus
death
beyond
first
year
lung
transplant
ltx
roughli
ltx
recipi
ltxr
clad
bronchiol
obliteran
syndrom
bo
includ
obstruct
restrict
phenotyp
term
restrict
allograft
syndrom
introduc
sato
et
al
diagnos
bilater
ltx
patient
clad
diagnosi
base
find
restrict
ventilatori
defect
radiograph
find
interstiti
opac
upper
zone
involv
previous
report
risk
factor
clad
includ
acut
reject
cytomegaloviru
cmv
pneumon
antibodi
ab
donor
human
leukocyt
antigen
hla
ab
nonhla
lungassoci
selfantigen
sag
primari
graft
dysfunct
respiratori
viral
infect
rvi
immunolog
mechan
underli
develop
clad
remain
unknown
therapi
establish
clad
gener
ineffect
rvi
ltx
associ
increas
risk
clad
fisher
et
al
conduct
larg
retrospect
studi
use
systemat
definit
adjud
assign
clad
blind
review
highli
sensit
specif
molecular
diagnosi
rvi
found
strong
independ
associ
symptomat
rvi
clad
studi
also
found
associ
rvi
clad
potenti
mechan
rviinduc
clad
pathogenesi
assess
recent
demonstr
ltxr
acut
chronic
reject
circul
exosom
contain
donormismatch
hla
lung
sag
immunoregulatori
microrna
exosom
stabl
ltxr
featur
studi
dieud
e
et
al
demonstr
presenc
proteasom
exosom
increas
immunogen
studi
test
hypothesi
rviinduc
allograft
injuri
may
induc
circul
exosom
contain
donor
hla
sag
viral
antigen
may
activ
donorspecif
immun
respons
increas
risk
clad
perform
retrospect
casecontrol
studi
adult
ltxr
diagnos
symptomat
upperandor
lowertract
rvi
case
adult
ltxr
rvi
diagnosi
control
patient
elig
studi
undergon
ltx
barnesjewish
hospit
washington
univers
st
loui
missouri
norton
thorac
institut
st
joseph
hospit
phoenix
arizona
store
serum
avail
baselin
patient
demograph
transplant
detail
laboratori
data
collect
patient
chart
patient
follow
least
year
clinic
laboratori
inform
collect
endpoint
bo
diagnos
accord
guidelin
intern
societi
heart
lung
transplant
rvi
test
perform
indic
compat
sign
symptom
patient
symptomat
rvi
includ
rvi
diagnos
use
biofir
filmarray
pcr
biom
erieux
marcyl
etoil
franc
detect
type
respiratori
virus
includ
adenoviru
coronaviru
type
human
metapneumoviru
human
rhinovirusenteroviru
influenza
b
parainfluenza
respiratori
syncyti
viru
rsv
upper
nasopharyng
swab
lower
bronchoalveolar
wash
lavag
specimen
includ
patient
consid
lowertract
infect
posit
lowertract
specimen
upper
respiratori
specimen
along
either
lower
respiratori
symptom
cough
wheez
declin
forc
expiratori
volum
ltxr
control
group
evid
symptomat
rvi
period
serum
collect
posttranspl
immunosuppress
compris
tripl
immunosuppress
regimen
tacrolimu
cyclosporin
mycophenol
mofetil
azathioprin
prednison
studi
approv
institut
review
board
washington
univers
st
joseph
hospit
laboratori
analys
perform
personnel
blind
clinic
outcom
clinic
endpoint
adjud
personnel
blind
laboratori
result
determin
ab
lung
sag
enzymelink
immunosorb
assay
elisa
elisa
use
analyz
serum
sampl
ltxr
diagnos
rvi
stabl
control
measur
ab
two
sag
collagenv
colv
tubulin
detail
previou
public
addit
lung
sag
use
kidneyassoci
sag
collageniv
coliv
meridian
control
sampl
consid
posit
valu
greater
mean
standard
deviat
healthi
control
valu
ab
concentr
calcul
use
standard
curv
known
concentr
colv
ab
bd
pharmingen
sanjos
ca
exosom
isol
serum
sampl
ltxr
rvi
stabl
control
ultracentrifug
previous
describ
exosom
puriti
valid
use
sucros
cushion
method
presenc
exosomespecif
marker
biolegend
san
diego
ca
alix
biolegend
assess
use
immunoblot
determin
lung
sag
proteasom
viral
antigen
use
immunoblot
immunoblot
use
detect
sag
proteasom
viral
antigen
exosom
ltxr
diagnos
rvi
stabl
control
total
exosom
protein
mg
resolv
polyacrylamid
gel
electrophoresi
protein
transfer
polyvinyliden
difluorid
membran
membran
block
nonfat
milk
phosphat
buffer
salin
probe
exosomespecif
marker
biolegend
colv
abcam
cambridg
unit
kingdom
santa
cruz
biotechnolog
dalla
tx
proteasom
subunit
santa
cruz
biotechnolog
rhinoviru
thermo
fisher
scientif
waltham
coronaviru
novu
biolog
littleton
co
rsv
glycoprotein
g
biorad
laboratori
hercul
ca
use
primari
ab
secondari
ab
conjug
horseradish
peroxidas
hrp
use
specif
primari
ab
blot
wash
pb
tween
thermo
fisher
scientif
develop
use
chemiluminesc
hrp
substrat
milliporesigma
burlington
expos
use
odyssey
clx
imag
system
licor
bioscienc
lincoln
ne
band
intens
target
protein
quantifi
use
imagej
softwar
normal
immun
mice
exosom
ltxr
diagnos
rvi
stabl
control
exosom
ml
isol
ltxr
rvi
stabl
control
use
immun
mice
day
prior
experi
demonstr
injuri
nativ
lung
requir
ab
lung
sag
caus
lesion
therefor
hydrochlor
acid
administ
intrabronchi
group
day
immun
exosom
serum
sampl
collect
day
use
detect
ab
colv
elisa
day
mice
kill
splenocyt
isol
enumer
sagspecif
cytokin
produc
cell
enzymelink
immunospot
assay
elispot
detect
ab
lung
sag
serum
sampl
mice
use
elisa
serum
sampl
mice
immun
exosom
ltxr
diagnos
rvi
stabl
control
use
measur
ab
colv
use
elisa
describ
previous
detect
murin
ab
use
conjug
hrp
secondari
ab
plate
develop
chemiluminesc
reagent
reaction
stop
n
hydrochlor
acid
optic
densiti
well
measur
wavelength
nm
serum
concentr
ab
lung
sag
calcul
use
standard
curv
obtain
known
concentr
ab
sag
sampl
consid
posit
valu
greater
mean
standard
deviat
healthi
control
valu
splenocyt
isol
mice
immun
exosom
ltxr
diagnos
rvi
stabl
control
elispot
perform
describ
previous
cytokineproduc
cell
analyz
spot
enumer
subtract
experiment
control
well
report
spot
per
million
lung
mice
immun
exosom
ltxr
rvi
stabl
ltxr
histolog
analyz
detect
lesion
cellular
infiltr
hematoxylin
eosin
trichrom
stain
describ
previous
lung
fix
formaldehyd
embed
paraffin
block
section
mm
thick
cut
mount
slide
leica
wetzlar
germani
hematoxylin
eosin
trichrom
stain
imag
obtain
leica
microscop
morphometr
analysi
perform
use
aperio
imagescop
softwar
leica
five
differ
area
examin
fibroprolifer
epitheli
abnorm
cellular
infiltr
slide
scan
whole
slide
imag
analyz
use
aperio
imag
scope
http
wwwleicabiosystemscomdigitalpathologymanageaperioimagescop
imagej
softwar
http
imagejnihgovij
analysi
infiltr
manual
annot
area
promin
well
mild
infiltr
perform
whole
slide
imag
fraction
total
tissu
area
promin
infiltr
determin
use
imag
scope
evalu
fibrosi
whole
slide
imag
lung
section
stain
trichrom
stain
export
tiff
file
color
deconvolut
tiff
file
perform
imagej
use
color
deconvolut
plugin
http
imagejnetcolourdeconvolu
tion
extent
bluestain
collagen
fibrosi
determin
use
standard
tool
avail
imagej
suit
data
analysi
perform
use
prism
softwar
graphpad
inc
ab
level
lung
sag
optic
densiti
exosom
contain
lung
sag
viral
antigen
rvi
ltxr
control
compar
use
twotail
student
ttest
indic
statist
data
cohort
express
mean
standard
error
pvalu
consid
statist
signific
compar
analysi
mean
optic
densiti
exosom
contain
lung
sag
viral
antigen
calcul
normal
exosomespecif
marker
compar
analysi
perform
use
u
test
patient
demograph
age
sex
ethnic
hlamismatch
statu
significantli
differ
group
tabl
acut
cellular
reject
acr
occur
rvi
acr
patient
acr
stabl
ltxr
control
acut
antibodymedi
reject
occur
patient
diagnos
rvi
none
stabl
ltxr
donorspecif
antibodi
develop
followup
figur
exosom
patient
diagnos
rsv
analyz
presenc
sag
rsv
glycoprotein
g
immunoblot
viral
antigen
seen
patient
rsv
infect
stabl
ltxr
viral
antigen
figur
furthermor
significantli
increas
level
sag
rsv
antigen
mean
optic
intens
demonstr
ltxr
diagnos
rsv
compar
stabl
ltxr
figur
immunoblot
result
show
coronaviru
antigen
detect
exosom
patient
diagnos
coronaviru
compar
stabl
ltxr
figur
level
sag
mean
optic
intens
colv
vs
p
vs
p
coronaviru
vs
p
significantli
higher
exosom
ltxr
coronaviru
stabl
ltxr
figur
twelv
patient
rhinoviru
infect
stabl
ltxr
select
detect
exosom
contain
sag
rhinoviru
antigen
patient
diagnos
rhinoviru
show
rhinoviru
antigen
stabl
ltxr
figur
mean
optic
densiti
exosom
contain
sag
mean
optic
intens
colv
vs
p
vs
p
rhinoviru
vs
p
significantli
higher
exosom
isol
ltxr
diagnos
rhinoviru
compar
stabl
ltxr
figur
determin
proteasom
exosom
isol
stabl
ltxr
n
ltxr
diagnos
rvi
n
perform
immunoblot
use
ab
subunit
proteasom
found
significantli
higher
level
proteasom
subunit
exosom
isol
ltxr
diagnos
rvi
compar
stabl
ltxr
mean
optic
densiti
ltxr
rvi
vs
stabl
ltxr
vs
p
alix
serv
exosomespecif
marker
load
control
figur
figur
exosom
contain
lungassoci
sag
ltxr
diagnos
rvi
stabl
ltxr
exosom
isol
serum
sampl
ltxr
rvi
n
stabl
ltxr
n
analyz
presenc
lungassoci
sag
colv
immunoblot
mean
rel
optic
densiti
colv
vs
p
vs
p
significantli
higher
ltxr
rvi
stabl
ltxr
optic
densiti
measur
use
imagej
softwar
od
valu
sag
calcul
ltxr
rvi
stabl
ltxr
normal
od
valu
also
serv
load
control
exosomespecif
marker
presenc
lung
sag
exosom
compar
cohort
use
test
asterisk
indic
statist
signific
colv
collagenv
tubulin
ltxr
lung
transplant
recipi
od
optic
densiti
rvi
respiratori
viral
infect
sag
selfantigen
lung
harvest
mice
immun
exosom
ltxr
rvi
stabl
ltxr
subject
histopatholog
analysi
mice
immun
exosom
ltxr
diagnos
rvi
show
inflammatori
cell
bronchiol
vessel
notabl
lesion
involv
bronchiol
cellular
infiltr
increas
fibrosi
also
observ
figur
contrast
signific
differ
cellular
infiltr
lesion
evid
mice
immun
exosom
stabl
ltxr
figur
lungassoci
sag
viral
antigen
demonstr
exosom
isol
patient
rvi
exosom
isol
serum
sampl
patient
rvi
stabl
ltxr
use
detect
presenc
lungassoci
sag
viral
antigen
use
immunoblot
result
show
signific
increas
lungassoci
antigen
viral
antigen
rsv
n
coronaviru
n
rhinoviru
n
respect
patient
viral
infect
compar
stabl
ltxr
n
b
graphic
represent
show
optic
densiti
lungassoci
sag
viral
antigen
measur
rvi
stabl
ltxr
use
imagej
softwar
optic
densiti
lung
sag
viral
antigen
normal
exosom
specif
marker
presenc
lung
sag
viral
antigen
exosom
compar
cohort
use
test
asterisk
indic
statist
signific
colv
collagenv
cv
coronaviru
tubulin
ltxr
lung
transplant
recipi
rsv
respiratori
syncyti
viru
rv
rhinoviru
rvi
respiratori
viral
infect
sag
selfantigen
exosom
contain
proteasom
core
ltxr
rvi
stabl
ltxr
circulatori
exosom
isol
ltxr
rvi
n
stabl
ltxr
n
use
detect
presenc
proteasom
subunit
use
immunoblot
exosom
isol
patient
rvi
show
signific
increas
proteasom
compar
exosom
stabl
ltxr
mean
optic
densiti
vs
p
alix
serv
load
control
exosomespecif
marker
b
graphic
represent
show
optic
intens
proteasom
subunit
abund
ltxr
viral
infect
stabl
ltxr
presenc
proteasom
compar
stabl
ltxr
ltxr
rvi
use
student
ttest
ltxr
lung
transplant
recipi
rvi
respiratori
viral
infect
result
demonstr
circul
exosom
ltxr
diagnos
rviinduc
cellular
infiltr
alveolar
lesion
lung
mice
furthermor
histopatholog
analysi
demonstr
interstiti
fibrosi
human
lung
transplant
similar
patholog
seen
restrict
allograft
syndrom
morphometr
data
figur
given
repres
imag
studi
demonstr
associ
rvi
clad
fisher
et
al
appli
molecular
diagnost
method
test
rvi
larg
cohort
ltxr
found
high
rate
rvi
also
demonstr
independ
associ
rvi
clad
suggest
studi
character
viral
determin
defin
mechan
rvi
increas
risk
clad
rvi
ltx
shown
dysregul
regulatori
cell
indic
rvi
lead
dysregul
toler
sag
lead
induct
immun
respons
sag
increas
risk
clad
studi
group
other
show
ab
lung
sag
shown
develop
correl
develop
clad
ltxr
preexist
ab
sag
also
report
increas
incid
primari
graft
dysfunct
induc
proinflammatori
cytokin
increas
develop
donorspecif
antibodi
clad
ltx
recent
demonstr
ltxr
diagnos
acut
chronic
reject
circul
exosom
express
mismatch
donor
hla
sag
propos
exosom
origin
transplant
lung
may
contribut
immun
pathogenesi
clad
ltx
base
find
postul
symptomat
rvi
may
induc
exosom
contain
sag
transplant
organ
persist
circul
exosom
sag
lead
immun
respons
result
increas
risk
clad
studi
determin
develop
ab
sag
ltxr
diagnos
rvi
result
present
figur
demonstr
ab
titer
sag
significantli
higher
patient
diagnos
rvi
stabl
ltxr
demonstr
rvi
induc
humor
immun
respons
sag
circul
exosom
isol
ltxr
diagnos
bo
express
mismatch
donor
hla
sag
colv
confirm
sourc
lung
allograft
suggest
exosom
induc
immun
respons
alloantigen
sag
increas
risk
clad
walker
et
al
demonstr
exosom
releas
cmvinfect
lung
endotheli
cell
ltxr
induc
tcell
respons
cmv
antigen
furthermor
human
nasopharyng
cell
line
transfect
epsteinbarr
viru
ebv
shown
releas
exosom
contain
viral
peptid
latent
membran
protein
fibroblast
growth
factor
exosom
isol
ebvtransform
b
cell
contain
ebv
viral
antigen
glycoprotein
specif
bind
b
cell
find
support
hypothesi
rvi
potenti
induc
exosom
contain
lung
sag
viral
antigen
transplant
recipi
rvi
result
demonstr
circul
exosom
isol
patient
diagnos
symptomat
rvi
sag
also
viral
antigen
studi
select
patient
diagnos
rsv
coronaviru
rhinoviru
demonstr
exosom
isol
patient
contain
specif
viral
antigen
along
sag
therefor
exosom
induc
follow
viral
infect
contain
viral
antigen
sag
preliminari
analysi
serial
circul
exosom
contain
viral
antigen
demonstr
ltxr
transient
presenc
circul
exosom
contrast
ltxr
rvi
persist
circul
exosom
lung
sag
viral
antigen
interest
find
need
confirm
determin
role
circul
exosom
induc
immun
respons
lead
clad
like
exosom
viral
antigen
epitop
activ
crossreact
cell
play
role
pathogenesi
clad
ltx
demonstr
exosom
isol
symptomat
patient
rvi
contain
increas
sag
viral
antigen
studi
identifi
use
threshold
exosom
ltxr
rvi
induc
humor
immun
respons
lung
sag
serum
sampl
collect
day
mice
immun
exosom
isol
ltxr
rvi
n
stabl
ltxr
n
util
measur
ab
lung
sag
elisa
serum
sampl
collect
day
mice
immun
exosom
ltxr
rvi
show
significantli
increas
ab
sag
colv
vs
p
vs
p
compar
mice
inject
exosom
stabl
ltxr
antibodi
develop
compar
cohort
use
student
ttest
asterisk
indic
statist
signific
ab
antibodi
colv
collagenv
elisa
enzymelink
immunosorb
assay
tubulin
ltxr
lung
transplant
recipi
rvi
respiratori
viral
infect
sag
selfantigen
concentr
could
potenti
serv
biomark
clad
studi
dieud
e
et
al
demonstr
exosom
isol
endotheli
cell
contain
proteasom
therefor
increas
immunogen
potenti
kidneyassoci
sag
perlecan
intraven
inject
exosom
mice
led
humor
immun
respons
perlecan
suggest
presenc
kidney
sag
along
proteasom
increas
immunogen
exosom
demonstr
exosom
contain
sag
along
viral
antigen
immunogen
isol
exosom
ltxr
rvi
stabl
ltxr
immun
mice
mice
immun
exosom
rvi
develop
increas
level
ab
sag
mice
immun
exosom
stabl
ltxr
addit
mice
immun
exosom
ltxr
rvi
show
increas
interferon
cell
reduc
cell
compar
mice
inject
exosom
stabl
ltxr
result
confirm
exosom
contain
sag
viral
antigen
proteasom
exosom
ltxr
rvi
induc
cytokineproduc
cell
lung
sag
spleen
collect
day
mice
immun
exosom
ltxr
rvi
n
stabl
ltxr
n
use
measur
cytokineproduc
cell
lung
sag
elispot
mice
immun
exosom
rvi
show
signific
increas
cell
produc
interferon
gamma
sag
mice
inject
exosom
isol
stabl
ltxr
show
increas
frequenc
cell
compar
mice
immun
rvi
exosom
cytokin
level
compar
cohort
use
test
asterisk
indic
statist
signific
elispot
enzymelink
immunospot
assay
il
interleukin
ltxr
lung
transplant
recipi
rvi
respiratori
viral
infect
sag
selfantigen
statist
signific
immunogen
induc
ab
sag
alter
tcell
cytokin
respons
lead
clad
studi
limit
exosom
isol
patient
diagnos
rvi
analyz
mice
model
oblit
airway
diseas
follow
lung
transplant
therefor
definit
conclud
exosom
patient
rvi
increas
incid
clad
develop
sampl
size
use
mous
model
small
use
pool
exosom
immun
therefor
role
individu
virus
induc
exosom
immunogen
conclud
studi
present
shown
serum
sampl
collect
ltxr
rvi
increas
ab
lung
sag
exosom
contain
lung
sag
viral
antigen
compar
stabl
ltxr
howev
viral
rna
exosom
role
immun
activ
need
determin
futur
studi
anoth
limit
role
individu
rvi
virus
induc
exosom
increas
risk
clad
determin
limit
avail
retrospect
collect
sampl
studi
howev
demonstr
exosom
deriv
ltxr
rviinduc
interstiti
fibrosi
inflammatori
cell
infiltr
adopt
transfer
exosom
gain
function
mice
model
suggest
rvi
exosom
suffici
induc
lesion
mice
similar
patholog
seen
restrict
allograft
syndrom
human
ltxr
demonstr
increas
humor
cellular
immun
respons
lung
sag
mice
immun
exosom
ltxr
rvi
compar
mice
immun
exosom
stabl
ltxr
base
propos
rviinduc
exosom
contain
lung
sag
viral
antigen
augment
humor
cellular
immun
respons
lung
sag
alloantigen
increas
risk
clad
result
strongli
suggest
biolog
plausibl
mechanist
link
rvi
induct
releas
circul
exosom
sag
develop
clad
assess
larg
prospect
cohort
fibrosi
cellular
infiltr
demonstr
mice
inject
exosom
isol
ltxr
rvi
mice
kill
day
lung
collect
analyz
use
hematoxylin
eosin
trichrom
stain
interstiti
inflammatori
infiltr
fibrosi
promin
mice
inject
exosom
ltxr
rvi
compar
mice
inject
exosom
stabl
ltxr
imag
obtain
leica
microscop
morphometr
analysi
perform
use
aperio
imagescop
softwar
leica
b
morphometr
data
given
repres
imag
ltxr
lung
transplant
recipi
rvi
respiratori
viral
infect
